Shire Unit Settles Genzyme False Advertising Suit
By Kat Greene ( February 25, 2014, 7:03 PM EST) -- A Massachusetts federal judge on Tuesday pulled the plug on a Genzyme Corp. suit accusing Shire Human Genetic Therapies Inc. of misleading consumers by advertising its genetic disease drug VPRIV as superior to Genzyme's Cerezyme after both parties said they'd reached a settlement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.